First drug that slows down Alzheimer’s disease already exists, but why doctors are skeptical?
Nine months after its introduction in the U.S., Eisai and Biogen’s Alzheimer’s drug Leqembi is encountering significant resistance in its widespread adoption, largely due to skepticism among some doctors about the efficacy of treating this degenerative brain disease.
Preparation for an MRI…
Source link